Standard Operating Procedure for Mixing and Blending of APIs and Excipients
Department | Capsule Manufacturing |
---|---|
SOP No. | SOP/CM/052/2025 |
Supersedes | SOP/CM/052/2022 |
Page No. | Page 1 of 6 |
Issue Date | 01/02/2025 |
Effective Date | 05/02/2025 |
Review Date | 01/02/2026 |
1. Purpose
The purpose of this SOP is to outline the procedure for mixing and blending Active Pharmaceutical Ingredients (APIs) with excipients in capsule formulation. Proper mixing and blending are crucial to ensure uniformity, consistency, and the desired efficacy of the final product.
2. Scope
This SOP applies to the mixing and blending process of APIs and excipients used in the formulation of capsule products. It covers the selection of materials, equipment, blending process, and quality control checks to ensure the homogeneous distribution of ingredients.
3. Responsibilities
- Formulation Development Team: Responsible for selecting the APIs and excipients, and designing the formulation with the appropriate ratios for the blending process.
- Manufacturing Team: Responsible for ensuring that the mixing and blending process is carried out as per the SOP, with the correct equipment and environmental conditions.
- Quality Control (QC) Team: Responsible for testing the blended materials to ensure uniformity, consistency, and compliance with specifications, such as content uniformity and moisture content.
- Quality Assurance (QA) Team: Ensures that the process follows GMP standards, reviews the documentation, and verifies compliance with regulatory guidelines.
4. Accountability
The Capsule Manufacturing Supervisor is accountable for ensuring the mixing and blending process is carried out according to this SOP. The QA Manager is responsible for ensuring that all quality checks and documentation are completed and compliant with regulatory standards.
5. Procedure
5.1 Selection of Raw Materials
Before starting the mixing and blending process, ensure the following steps are taken:
-
API Selection
- Ensure that the active pharmaceutical ingredient (API) is sourced from an approved supplier and is of the correct quality and batch for use in the formulation.
- Verify that the API meets the required specifications for potency, purity, and other physical characteristics.
-
Excipient Selection
- Select excipients based on the formulation requirements, such as binders, fillers, disintegrants, lubricants, and colorants.
- Ensure excipients are compatible with the API and comply with quality standards.
-
Weighing of Ingredients
- Weigh the API and excipients according to the formulation specifications. Use a calibrated balance to ensure accuracy in measurement.
- Document the batch number and weight of each ingredient for traceability.
5.2 Mixing and Blending Process
The following steps should be followed during the mixing and blending process:
-
Preparing Equipment
- Ensure that all mixing equipment, such as blenders or ribbon blenders, is clean and properly calibrated before use.
- Verify that the equipment is free from any contaminants or residues from previous batches.
-
Initial Blending
- Begin by blending the excipients together in the designated mixing equipment. This ensures that the excipients are thoroughly combined before adding the API.
- Blend for the specified time to achieve a uniform mixture of excipients.
-
Adding API
- Slowly add the API to the blended excipients, ensuring even distribution throughout the excipient mix. Use the appropriate mixing speed and duration to prevent API degradation or loss.
- Monitor the blending process to ensure that the API is evenly distributed and no lumps or agglomerates are formed.
-
Secondary Blending
- Blend the mixture for an additional period to ensure the uniformity of the final blend. Periodically check the consistency of the mixture and adjust blending time if necessary.
5.3 Quality Control Checks
Once the mixing and blending process is complete, perform the following quality control checks:
-
Homogeneity Test
- Conduct a sample from the blend and test for homogeneity. The API should be evenly distributed across the excipients. Perform a content uniformity test to check for variation in the API content across different parts of the blend.
-
Moisture Content Test
- Test the moisture content of the blend to ensure it is within the acceptable range. Excess moisture may affect the flowability of the blend and cause caking or difficulty in capsule filling.
-
Particle Size Distribution
- Check the particle size distribution of the blend, especially if fine powders or granules are used. Ensure that the blend has the desired flowability and can be effectively encapsulated.
5.4 Documentation and Record-Keeping
Ensure proper documentation of the entire mixing and blending process:
-
Batch Records
- Document the complete batch record for each mixing and blending run, including details of the ingredients, equipment used, mixing time, and any observations made during the process.
-
Test Results
- Record the results of all quality control tests performed, including homogeneity, moisture content, and particle size distribution.
-
Deviation Reports
- If any deviations occur during the blending process, document them in a deviation report and provide details on the corrective actions taken.
5.5 Storage of Blended Materials
If the blend is not used immediately for capsule filling, store it under appropriate conditions:
-
Container and Storage
- Store the blended material in clean, airtight containers to prevent contamination and moisture uptake.
- Label the containers with the batch number, date of blending, and storage conditions.
-
Temperature Control
- Store the blended material in a controlled environment, maintaining a temperature range of 20°C to 25°C. If necessary, store in a climate-controlled room to maintain blend quality.
6. Abbreviations
- SOP: Standard Operating Procedure
- API: Active Pharmaceutical Ingredient
- GMP: Good Manufacturing Practice
- QC: Quality Control
- QA: Quality Assurance
7. Documents
- Mixing and Blending Batch Record (Annexure-1)
- Quality Control Test Report (Annexure-2)
- Deviation Report (Annexure-3)
8. References
- USP <601> – Capsules
- FDA Guidelines for Pharmaceutical Manufacturing
- International Conference on Harmonization (ICH) Guidelines for Pharmaceutical Product Development
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Mixing and Blending Batch Record
Batch ID | API | Excipients | Weighed Amount | Blending Time | Remarks |
---|---|---|---|---|---|
Batch 001 | Vitamin C | Magnesium Stearate, Lactose | 100 g | 20 minutes | No deviation |
Annexure-2: Quality Control Test Report
Test Type | Result | Specification | Remarks |
---|---|---|---|
Homogeneity | Pass | Uniform distribution | Meets standards |
Annexure-3: Deviation Report
Deviation ID | Description | Corrective Action | Action Taken By |
---|---|---|---|
DR-001 | Excess moisture in blend | Drying blend for 30 minutes | Manufacturing Supervisor |
Revision History:
Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
---|---|---|---|---|
01/01/2024 | 1.0 | Initial Version | New SOP Creation | QA Head |
01/02/2025 | 2.0 | Added deviation management | Standardization | QA Head |